Travere Therapeutics Announces Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal…
<!-- Name:DistributionId Value:8829311 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:True -->
<!-- Name:IcbCode Value:4570 -->…